Back
 JBM  Vol.4 No.9 , September 2016
Endothelial Nitric Oxyde Synthase Gene Polymorphisms in a Tunisian Deep Vein Thrombosis Group
Abstract: Deep vein thrombosis (DVT) is a multi-factorial disease involving both genetic and acquired risk factors. The objective of this study was to determine the frequencies of endothelial nitric oxide synthase (eNOS) gene polymorphisms G894T (rs1799983) and T-786C (rs2070744) to assess the role of these polymorphisms as a potential risk factor in the development of DVT. Methods: In this case-control study, we included 32 patients with deep vein thrombosis (DVT) and 31 healthy control subjects. Clinical characteristics were collected. Lipids plasma concentrations were determined by the colorimetric method. Genotyping for the polymorphisms was performed by restriction fragment length polymorphism (PCR-RFLP) method. Results: We had found that the eNos G894T genotype G/T was significantly increasing the risk of DTV (P = 0.042, OR = 3.9; 95% CI = 1.09 to 13.92). But no association of the eNOS T-786C variant and DVT was found. For the eNOs T-786C polymorphism, the frequency of the T/T genotype was 87.5% in patients (with an allelic frequency of T Allele equal to 91%). No significant difference was noted between the two groups (P > 0.05). Conclusion: The eNOs G894T polymorphism seems to be in association with DVT and may be considered as a risk factor, but this is not the case for the T-786C polymorphism.
Cite this paper: Grira, N. , Abdelhafidh, N. , Ayoub, M. , Sendesni, R. , Adib, B. , Stambouli, N. , Othmani, S. , Aouni, Z. and Mazigh, C. (2016) Endothelial Nitric Oxyde Synthase Gene Polymorphisms in a Tunisian Deep Vein Thrombosis Group. Journal of Biosciences and Medicines, 4, 33-41. doi: 10.4236/jbm.2016.49004.
References

[1]   Vascular Disease Foundation (2012).
http://vasculardisease.org/flyers/deep-vein-thrombosis-flyer.pdf

[2]   Bertina, R.M. (2001) Genetic Approach to Thrombophilia. Thrombosis and Haemostasis, 86, 92-103.

[3]   José, A.L. (2009) Pathophysiology of Venous Thrombosis. Thrombosis Research, 123, 30- 34.
http://dx.doi.org/10.1016/S0049-3848(09)70140-9

[4]   Maiike, S., Roel, V. and Harry, R.B. (2009) Deep Vein Thrombosis and Pulmonary Embolism. John Wiley and Sons, Ltd., Chichester.

[5]   Martinelli, I. (2001) Risk Factor in Venous Thromboembolism. Thrombosis and Haemostasis, 86, 395-403.

[6]   Akhter, M.S., Biswas, A., Ranjan, R., Sharma, A., Kumar, S. and Saxena, R. (2010) The Nitric Oxide Synthase 3 Gene Polymorphisms and Their Association with Deep Vein Thrombosis in Asian Indian Patients. Clinica Chimica Acta, 411, 649-652.
http://dx.doi.org/10.1016/j.cca.2010.01.025

[7]   Ben Ali, M., Safia, M., Houda, E. and Touhami, M. (2015) Contribution of eNOS Variants to the Genetic Susceptibility of Coronary Artery Disease in a Tunisian Population. Genetic Testing and Molecular Biomarkers, 4, 203-208.
http://dx.doi.org/10.1089/gtmb.2014.0261

[8]   Li, Y.Y., Zhai, Z.G., Yang, Y.H., Pang, B.S., Wang, H.Y., Zhang, W., Zhao, L., Wang, J. and Wang, C. (2011) Association of the 894G>T Polymorphism in the Endothelial Nitric Oxide Synthase Gene with Risk of Venous Thromboembolism in Chinese Population. Thrombosis Research, 127, 324-327.
http://dx.doi.org/10.1016/j.thromres.2010.11.034

[9]   Lianxing, Z., Chunsheng, L., Qin, Y., Qian, Z., Rui, S. and Yingying, F. (2014) Endothelial Nitric Oxide Synthase 894 G>T Polymorphism and Thrombotic Disease: A Meta-Analysis of 17 Studies Involving 8808 Subjects. Thrombosis Research, 134, 1057-1065.
http://dx.doi.org/10.1016/j.thromres.2014.07.014

[10]   Heit, J.A., Silversein, M.D., Mohr, D.N., Petterson, T.M., O’fallon, W.M. and Melton, L.J. (1999) Predictors of Survival after Deep Vein Thromsosis and Pulmonary Embolism: A Population-Based, Cohort Study. Archives of Internal Medicine, 159, 445-453.
http://dx.doi.org/10.1001/archinte.159.5.445

[11]   Ying, L. and Hofseth, LJ. (2007) An Emerging Role for Endothelial Nitric Oxide Synthase in Chronic Inflammation and Cancer. Cancer Research, 15, 1407-1410.
http://dx.doi.org/10.1158/0008-5472.CAN-06-2149

[12]   Elif, S., Omer, N.E., Faruk, S. and Yusuf, O. (2014) The role of Endothelial Nitric Oxide Synthase Gene G894T and Intron 4 VNTR Polymorphisms in Hemodialysis Patients with Vascular Access Thrombosis. The Anatolian Journal of Cardiology, 14, 239-243
http://dx.doi.org/10.5152/akd.2013.4779

[13]   Forstermann, U. and Munzel, T. (2006) Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace. Circulation, 113, 1708-1714.
http://dx.doi.org/10.1161/CIRCULATIONAHA.105.602532

[14]   Tesauro, M., Thompson, W.C., Rogliani, P., Qi, L., Chaudhary, P.P. and Moss, J. (2000) Intracellular Processing of Endothelial Nitric Oxide Synthase Isoforms Associated with Differences in Severity of Cardiopulmonary Diseases: Cleavage of Proteins with Aspartate vs. Glutamate at Position 298. Proceedings of the National Academy of Sciences of the United States of America, 97, 2832-2835.
http://dx.doi.org/10.1073/pnas.97.6.2832

[15]   Giorgio, G., Maria, L.B., Marco, D.M., Mara, B., Olivia, T., Federico, G. and Roberto, S. (2002) Independent Risk Factor for Moderate to Severe Internal Carotid Artery Stenosis: T786 Mutation of the Endothelial Nitric Oxide Synthase Gene. Clinical Chemistry, 48, 989-993.

 
 
Top